ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 12.10
-1.05 (-7.98%)
Nov 7, 2025, 3:11 PM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 93.59 million as of November 7, 2025. Its market cap has increased by 164.02% in one year.
Market Cap
93.59M
Enterprise Value
89.25M
Revenue
8.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.10
Market Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 93.59M, a decrease of -63.90%. That is a compound annual growth rate of -12.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 93.59M | 14.15% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | 254.51M | 144.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.36T |
| Coloplast | 138.56B |
| Genmab | 113.20B |
| Demant | 48.14B |
| ALK-Abelló | 45.03B |
| H. Lundbeck | 43.53B |
| Zealand Pharma | 33.59B |
| Ambu A/S | 22.16B |